US Patent 10934550 Immunotherapy of cancer
Patent 10934550 was granted and assigned to Phio Pharmaceuticals on March, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10934550 Immunotherapy of cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.